Jump to content

Ellipta

From Wikipedia, the free encyclopedia

Ellipta is part of GlaxoSmithKline's trade names of several inhalable asthma and chronic obstructive airway disease (COPD) combination medications that make use of the same type of inhaler:

Further reading

[edit]
  • Grant AC, Walker R, Hamilton M, Garrill K (2015). "The ELLIPTA Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers". J Aerosol Med Pulm Drug Deliv. 28 (6): 474–85. doi:10.1089/jamp.2015.1223. PMC 4685506. PMID 26372466.